Find your path to Ben
219 people in our graph share verified history with Ben — schools, employers, funds. One of them is your warm intro.
Francesco De RubertisunlockedBen: together at Medicxi (2022–2026)
×10Ben: together at Medicxi
Ben: together at Swansea University / Prifysgol Abertawe
About
Ben Perry spent two decades in drug discovery at DNDi, Addex and UCB, co-founded AiDD SA and MPC Therapeutics SA, and maintains active publications and deep medicinal chemistry expertise.
Invests in
BiotechDigital HealthHealthtechMedical Devices
Experience
- MedicxiVenture Partnercurrent2022 — presentGeneva, Switzerland
- MPC TherapeuticsCo-Founder, SAB membercurrent2018 — present
- Various CompaniesAdvisory Board Membercurrent2018 — present
- Drugs for Neglected Diseases initiative - DNDiDiscovery Leader2015 — 2022Geneva, Geneva, Switzerland
- Genkyotex S.AHead of Chemistry2015 — 2017Geneva, Geneva, Switzerland
- BPMedChem ConsultingFounder, Consultant2014 — 2017Geneva, Geneva, Switzerland
- AIDD - Alpine Institute for Drug DiscoveryCo-Founder2013 — 2017Geneva, Geneva, Switzerland
- Addex PharmaceuticalsAssociate Research Director2008 — 2013Geneva, Geneva, Switzerland
- UCB PharmaPrincipal Scientist, Medicinal Chemistry2003 — 2008
- University of Colorado at BoulderResearcher1997 — 1998
Skills & more
Venture CapitalDrug Discovery37Medicinal Chemistry36Lead Change7Drug Design17GPCRs13Organic Synthesis4Organic Chemistry7DMPK1Pharmaceutical Industry10ADME4Chemistry18
+9 more
Parallel SynthesisPharmacologyLC-MSDrug DevelopmentHigh Throughput ScreeningIn VitroBiotechnologyBiochemistryLifesciencesLanguages English · French
From Ben's professional profile.
Investments
Investor
Cosmyc TherapeuticsMy-T BioPetalion Therapeutics
Per the firm's website.
Colleagues at Medicxi
Frequently asked questions
- Who is Ben Perry?
- Ben Perry spent two decades in drug discovery at DNDi, Addex and UCB, co-founded AiDD SA and MPC Therapeutics SA, and maintains active publications and deep medicinal chemistry expertise.
- Where does Ben Perry work?
- Ben Perry is Venture Partner at Medicxi.
- What does Ben Perry invest in?
- Ben Perry invests in Biotech, Digital Health, Healthtech, Medical Devices.
- What companies has Ben Perry invested in?
- Investments tracked here include Cosmyc Therapeutics, My-T Bio, Petalion Therapeutics.
- Where did Ben Perry go to school?
- Ben Perry studied at Imperial College London (Ph.D., Synthetic Organic Chemistry); IE Business School (EMBA); Swansea University / Prifysgol Abertawe (MChem, Chemistry).
Same school
Also attended Imperial College London765
Deji SasegbonVP, Platform & Portfolio Operations at EchoVC PartnersMadison LenormandInvestor at DaphniLoubaba El AyoubiInvestor at NorthzoneGiovanni MariggiInvestor at MedicxiFrancois PrinslooInvestor at MedicxiCharles GrummittInvestor at Medicxi
+ 759 more
Also attended IE Business School331
Borja FernándezGeneral Partner at Inveready Technology Investment GroupGabriel FarmeInvestor at Graphene VenturesHayata TokizawaVice President at Fin CapitalIñaki ArrolaInvestor at KfundCarina SzpilkaInvestor at KfundMiguel ElizondoInvestor at Kfund
+ 325 more
Also attended Swansea University / Prifysgol Abertawe34
Olivia FoyleInvestor at DN CapitalNick MoonChair at Circulate CapitalKen HorneDirector, Portfolio Operations at Spring Lane CapitalOmisha ChhetriFinance and Operations at Audacity Venture CapitalStephen PriceInvestment Director at Clean Growth FundRebecca Garrod-WatersCEO at Ufi VocTech Trust
+ 28 more
Shared employers
Also worked at Drugs for Neglected Diseases initiative - DNDi1
Also worked at Genkyotex S.A1
Also worked at Addex Pharmaceuticals2
Also worked at UCB Pharma27
Stephen RapeckiInvestor at MedicxiMary PattonScientific Advisory Board at InnoCom Bio EquitiesMiguel ForteAdvisor at Delin VenturesJohn LeonardExecutives in Residence at GENERAL INCEPTIONSam GrayManaging Partner at Apposite CapitalDavid DevigneInvestment Director at Korys
+ 21 more